“This research reaffirms that EMPowerplus™
Dr. Julia Rucklidge and her team of researchers successfully completed the placebo-controlled study, which was published January 30th in the British Journal of Psychiatry. In the study researchers reported:
“We demonstrated that micronutrient treatment induced statistically robust improvements in several indices… Specifically, participants taking the micronutrient formula reported greater improvement in both inattention and hyperactivity/
Dr. Rucklidge states in the publishing, “These results are consistent with a review of over 140 patients treated with this micronutrient formula, which did not identify any significant adverse effects or safety concerns.”
The research publication also identified a major reduction in symptoms of depression (using the MADRS depression rating scale) in those suffering with moderate to severe depression. “A further exploration of the MADRS scores revealed a significant difference in favoring the micronutrient group when a subsample of those with moderate or severe depression at baseline was examined.”
In addition, the researchers stated that 47.6% of the micronutrient group was “much” to “very much improved” over the eight-week study.
The micronutrient formula known as EMPowerplus™